S100A16 and neoplasm: According to the studies [27,50], we found that the upregulation of CRISP3, S100A13, and S100A16 in domain 3 suggests that this region possesses tumor invasiveness, metastatic potential, and an active inflammatory environment, thereby promoting tumor progression.